NCT04576871 2025-08-28
Re-treatment 225Ac-J591 for mCRPC
Weill Medical College of Cornell University
Phase EARLY_PHASE1 Completed
Clinical Trials
26 trialsNCT05547386 2025-07-18
68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy for Patients With Metastatic Castrate Resistant Prostate Cancer
Mayo Clinic
Phase 3 Completed
NCT02920229 2025-01-09
GaPSMA
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Phase NA Completed
NCT02952469 2024-09-03
Biodistribution/Reproducibility Ga-68 PSMA-HBED-CC
University of Iowa
Phase EARLY_PHASE1 Completed
NCT03276572 2024-06-13
Phase I Trial of 225Ac-J591 in Patients With mCRPC
Weill Medical College of Cornell University
Phase 1 Completed
NCT05527483 2024-05-16
Digital PET/CT Using [Ga-68]PSMA vs. [F-18]NaF for Evaluation of Osseous Metastatic Involvement in Prostate Cancer Patients
University Hospitals Cleveland Medical Center
Completed
NCT03822871 2024-03-21
A Trial of CTT1403 for Metastatic Castration Resistant Prostate Cancer
Cancer Targeted Technology
Phase 1 Completed
NCT04867603 2023-12-19
Digital PET/CT Using [Ga-68]PSMA for Characterization of Prostate Lesions
Case Comprehensive Cancer Center
Completed
NCT03001869 2023-11-27
68Ga-PSMA PET/CT in Prostate Cancer
Sir Mortimer B. Davis - Jewish General Hospital
Phase 3 Completed
NCT03396874 2023-11-03
Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrence
University of Michigan
Phase 2 Completed
NCT04614363 2023-08-28
68 Ga-PSMA for High Risk Prostate Cancer
The Methodist Hospital Research Institute
Phase 1/2 Completed
NCT02659527 2023-06-15
PET/MRI in Patients With Suspected Prostate Cancer
Medical University of Vienna
Phase 3 Completed
NCT04976257 2023-04-07
Pharmacokinetics of IA and IV Ga68-PSMA-11 Infusion
University of California, San Francisco
Phase EARLY_PHASE1 Completed
NCT04179968 2023-03-20
The Role of 68Gallium PSMA-11 in Enhancing Diagnosis of Primary and Metastatic Prostate Cancer
University of Texas Southwestern Medical Center
Phase 2 Completed
NCT02673151 2022-01-13
68Ga-PSMA PET/CT in Detecting Prostate Cancer Recurrence in Patients With Elevated PSA After Initial Treatment
Stanford University
Phase 2/3 Completed
NCT03353740 2021-10-21
Gallium-68 PSMA-11 Positron Emission Tomography (PET) Imaging in Patients With Biochemical Recurrence
University of California, San Francisco
Phase 3 Completed
NCT04050215 2021-09-30
68GA-PSMA-11 PET/CT Scan in Impacting Treatment Strategies for Patients With Prostate Cancer
Jonsson Comprehensive Cancer Center
Phase 2 Completed
NCT03187990 2021-09-02
Positron Emission Tomography / Magnetic Resonance Imaging (PET/MRI) Guided Biopsy in Men With Elevated PSA
University of Zurich
Phase NA Completed
NCT03803475 2021-08-24
Gallium-68 PSMA-11 PET Imaging in Prostate Cancer Patients
University of California, San Francisco
Phase 3 Completed
NCT03977610 2021-07-28
The Role of Ga68-PSMA-11 PET Imaging in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy
Chang Gung Memorial Hospital
Phase NA Completed
NCT02611882 2020-12-22
PSMA PET
University of California, San Francisco
Phase 2 Completed
NCT04282824 2020-12-02
MSG PSMA PET
Jonsson Comprehensive Cancer Center
Phase EARLY_PHASE1 Completed
NCT03675451 2020-10-14
PSMA Imaging of Localized Prostate Cancer
Weill Medical College of Cornell University
Phase 2 Completed
NCT03362359 2020-07-27
Ga-68-PSMA-11 in High-risk Prostate Cancer
German Cancer Research Center
Phase 1/2 Completed
NCT03207139 2019-07-17
Ga-68 PSMA Ligand: A Radiopharmaceutical for Localization of Prostate Cancer
Chang Gung Memorial Hospital
Phase 2 Completed
NCT02488070 2018-03-20
68Ga-PSMA PET/CT or PET/MRI in Evaluating Patients With Recurrent Prostate Cancer
Stanford University
Phase 1/2 Completed